Status:
COMPLETED
Prebiotic GOS and Lactoferrin With Iron Supplements
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Swiss Federal Institute of Technology
Jomo Kenyatta University of Agriculture and Technology
Conditions:
Iron-deficiency
Eligibility:
All Genders
21-27 years
Phase:
NA
Brief Summary
The ultimate goal of this research is to develop a means to safely administer iron supplements to infants in settings with a high infection burden. The investigators will conduct a randomized clinical...
Detailed Description
Iron deficiency, the principal cause of anemia globally, affects more than two billion individuals, predominantly infants, children and women of childbearing age. Iron deficiency impairs cognitive and...
Eligibility Criteria
Inclusion
- vaginal or cesarean delivery
- an infant age of 6 months (±3 weeks)
- mother ≥15 years of age
- infant still breastfeeding
- anticipated residence in the area for the study duration.
Exclusion
- inability to provide informed consent
- hemoglobin \< 70 g/L
- Z scores for weight-for-age (WAZ) or weight-for-height (WHZ) \<3,
- any maternal or infant chronic illness
- administration of any infant vitamin or mineral supplements for the past 2 months
- history of infant antibiotic treatment within 7 days before study enrollment.
Key Trial Info
Start Date :
January 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2023
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT03866837
Start Date
January 15 2020
End Date
April 30 2023
Last Update
January 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jomo Kenyatta University of Agriculture and Technology
Nairobi, Kenya, 00200
2
Swiss Federal Institute of Technology (ETH Zürich)
Zurich, Switzerland, 8092